Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-18 Option Award | 2023-12-20 5:23 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 25,362 | $0 | 225,631 (Direct) | View |
| 2023-03-01 Option Award | 2023-04-21 6:13 pm | N/A 2033-02-28 | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 202,900 | $0 | 301,719 (Direct) | View |
| 2022-05-31 Option Award | 2022-12-02 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 5,023 | $1.5385 | 98,819 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 3,781 | $1.241 | 98,819 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-04 4:45 pm | N/A 2032-03-31 | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 116,700 | $0 | 116,700 (Direct) | View |
Ownership | 2021-11-01 8:30 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 0 | $0 | 195,521 (Direct) | View |